NEWS
-
Company News2025: Four Keywords, Capturing the Defining Moments of Dunwill MedicalOriginality, Translation, Recognition, Warmth2026. 01. 19
-
Company NewsThe Echo of Dunwill Medical at the 2026 Standardization Initiative - Chinese Liver Cancer Academic Annual ConferenceShanghai, January 10 – At the "2026 Standardization Initiative - Chinese Liver Cancer Academic Annual Conference," the expert finalization and release of the National Health Commission's "Guideli...2026. 01. 14 -
Company NewsUnmasking the "Silent Killer": Dunwill Medical's miRNA7 Supports the "Green Ribbon" Liver Cancer Early Screening InitiativeOn January 6, 2026, the launch ceremony for the "Green Ribbon Liver Cancer Early Screening and Diagnosis Plan" (the "Green Ribbon Plan") was officially held in Shanghai by Zhongshan Hospital, Fudan University. To further empower early screening and diagnosis of liver cancer, the hospital will provide a complimentary public-benefit screening activity, integrating technological innovation into safeguarding public health. Dunwill Medical's originally developed innovative molecular biomarker for liver cancer early diagnosis—miRNA7—was selected for this plan due to its exceptional performance in detecting very early-stage disease.2026. 01. 13 -
Company NewsSynergistic Empowerment, Charting a New Course | Zhongshan-Dunwill Original Innovation Cooperation Continues to UpgradeOn December 11, the 6th Fudan Zhongshan Patent Salon & the 1st Medical Science Innovation and Translation Training Course, themed "Integrating Medicine, Research, and Industry, Empowering New Developm...2025. 12. 15 -
Company NewsMedical-Enterprise Collaboration Leads a New Chapter in Precision MedicineRecently, two BCR::ABL1 quantitative detection methods (RT-qPCR and digital PCR) from the Clinical Laboratory of the Hematology Institute at Ruijin Hospital, affiliated with Shanghai Jiao Tong Univers...2025. 12. 03 -
Company NewsA New Era in Liver Cancer Diagnosis and Treatment: Asia-Pacific Perioperative Invitational Tournament Concludes Successfully, Original Chinese Research Leads the WayOn November 15, 2025, the Shanghai Longemont Hotel hosted the grand opening of the "Who Competes with the Best" Asia Liver Cancer Perioperative Invitational Tournament. This conference brought togethe...2025. 11. 25 -
Company NewsGreat News! Dunwill Medical Honored with the "Original Biomarkers Development Company of the Year in Asia 2025" AwardRecently, Dunwill Medical was awarded the "Original Biomarkers Development Company of the Year in Asia 2025" award, recognizing its outstanding achievements in the development and translation of origi...2025. 11. 21 -
Company NewsAchieving New Success! Dunwill Medical Wins Award at 2025 CACA Integrated Cancer Prevention and Control Sci-Tech Innovation Competition, Contributing to a New Journey in Cancer Prevention and ControlOn November 7th, the "2025 CACA Integrated Cancer Prevention and Control Sci-Tech Innovation Competition Grand Finals" successfully concluded in Kunming, Yunnan. Hosted by the China Anti-Cancer Associ...2025. 11. 10 -
Company NewsJinan Autumn Rhythms Inspire New Thinking: AI Leads a New Paradigm in Early Liver Cancer Screening – Highlights from Dunwill Medical’s Special Session at NCLMIn the golden autumn season, Jinan, the "Spring City," hosted the annual grand event in the field of laboratory medicine – the 19th National Conference on Laboratory Medicine of the Chinese Medical A...2025. 11. 03 -
Company NewsYour Safety, Our Deepest Concern: Dunwill Medical's 2025 Annual Safety Activities Warmly CommenceSafety is the cornerstone of enterprise development, the core task for safeguarding employees' lives and health, and maintaining stable company operations. To continuously strengthen all employees...2025. 10. 27



